Neutral sphingomyelinase inhibitor C11AG prevents lipopolysaccharide-induced macrophage activation.

Drugs Exp Clin Res

German Cancer Research Center, Abteilung Immunregulation und Tumorabwehr, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

Published: October 2003

Stimulation of macrophages by lipopolysaccharide (LPS) leads to the synthesis of proinflammatory cytokines and nitric oxide (NO) and, as a consequence, to endotoxic shock. We provide evidence that LPS stimulates the activity of a membrane-associated neutral sphingomyelinase (nSMase) and that this activity is mandatory for the liberation of nuclear factor-kappa B (NF kappa B) and the induction of inducible NO-synthase (iNOS). With the aid of a newly developed, selective inhibitor of nSMase, C11AG, we could distinguish between nSMase-dependent and -independent LPS-induced signals. C11AG blocked LPS-stimulated sphingomyelin degradation and NF kappa B activation without interfering with p42 tyrosine phosphorylation. Concomitantly, the expression of iNOS was found to be reduced both in mononuclear cells and in murine endotoxemia. Therefore, specific inhibitors of nSMase may define a new class of antiinflammatory substances.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neutral sphingomyelinase
8
sphingomyelinase inhibitor
4
inhibitor c11ag
4
c11ag prevents
4
prevents lipopolysaccharide-induced
4
lipopolysaccharide-induced macrophage
4
macrophage activation
4
activation stimulation
4
stimulation macrophages
4
macrophages lipopolysaccharide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!